摘要
应用免疫组化法对83例正常乳腺、乳腺非典型增生和乳腺癌组织的p53基因蛋白进行检测。正常乳腺组织无p53基因蛋白表达,单纯乳腺上皮增生、轻度非典型增生、中重度非典型增生和乳腺癌的阳性表达率分别是5.88%(1/17),16.67%(3/18),33.33%(6/18)和40%(10/25)。增生与癌变之间有显著性差异(P<0.05),结果表明乳腺癌癌前病变中有p53基因蛋白表达。免疫组化检测乳腺非典型增生组织中的p53蛋白对评估癌前病变的恶性倾向有重要意义。
Expression of p53 gene protein in 83 cases of normal mammary gland, atypical hyperplasia and breast cancer tissue were determined by immunohistochemical method. There was no p53 gene protein expression found in normal mammary gland, while the positive rates in simple epithelial hyperplasia, mild atypical hyperplasia, moderate or severe atypical hyperplasia and breast carcinoma cases were 5.88%(1/17),16.67%(3/18) 33.33%(6/18) and 40%(10/25) (P<0.05)respectively with significant difference between hyperplasia and malignant change. The results indicate that p53 gene protein expression exists in the precancerous lesions and that immunohistochemical examination is of significance in assessing the tendency of malignant change of breast lesion.
出处
《中国肿瘤临床》
CAS
CSCD
北大核心
1998年第2期116-118,共3页
Chinese Journal of Clinical Oncology